Cargando…

Safety and efficacy of doxycycline in the treatment of rosacea

Rosacea is a common, chronic, skin condition characterized by recurrent episodes of facial flushing, transient or persistent erythema, papules, pustules, and telangiectasias, in a symmetrical facial distribution. The etiology of rosacea remains unknown and this condition represents a therapeutic cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Valentín, Sheila, Morales, Adisbeth, Sánchez, Jorge L, Rivera, Abimael
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047926/
https://www.ncbi.nlm.nih.gov/pubmed/21436975
_version_ 1782199100624601088
author Valentín, Sheila
Morales, Adisbeth
Sánchez, Jorge L
Rivera, Abimael
author_facet Valentín, Sheila
Morales, Adisbeth
Sánchez, Jorge L
Rivera, Abimael
author_sort Valentín, Sheila
collection PubMed
description Rosacea is a common, chronic, skin condition characterized by recurrent episodes of facial flushing, transient or persistent erythema, papules, pustules, and telangiectasias, in a symmetrical facial distribution. The etiology of rosacea remains unknown and this condition represents a therapeutic challenge because of its chronic nature, progression, potential for disfigurement and psychological impact. Although there is no curative therapy for rosacea, the most widely used systemic agents are oral tetracycline derivatives, including tetracycline, doxycycline, and minocycline. This article reviews the available evidence for the use of doxycycline, a second-generation tetracycline, in the treatment or rosacea.
format Text
id pubmed-3047926
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30479262011-03-23 Safety and efficacy of doxycycline in the treatment of rosacea Valentín, Sheila Morales, Adisbeth Sánchez, Jorge L Rivera, Abimael Clin Cosmet Investig Dermatol Review Rosacea is a common, chronic, skin condition characterized by recurrent episodes of facial flushing, transient or persistent erythema, papules, pustules, and telangiectasias, in a symmetrical facial distribution. The etiology of rosacea remains unknown and this condition represents a therapeutic challenge because of its chronic nature, progression, potential for disfigurement and psychological impact. Although there is no curative therapy for rosacea, the most widely used systemic agents are oral tetracycline derivatives, including tetracycline, doxycycline, and minocycline. This article reviews the available evidence for the use of doxycycline, a second-generation tetracycline, in the treatment or rosacea. Dove Medical Press 2009-08-12 /pmc/articles/PMC3047926/ /pubmed/21436975 Text en © 2009 Valentín et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Valentín, Sheila
Morales, Adisbeth
Sánchez, Jorge L
Rivera, Abimael
Safety and efficacy of doxycycline in the treatment of rosacea
title Safety and efficacy of doxycycline in the treatment of rosacea
title_full Safety and efficacy of doxycycline in the treatment of rosacea
title_fullStr Safety and efficacy of doxycycline in the treatment of rosacea
title_full_unstemmed Safety and efficacy of doxycycline in the treatment of rosacea
title_short Safety and efficacy of doxycycline in the treatment of rosacea
title_sort safety and efficacy of doxycycline in the treatment of rosacea
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047926/
https://www.ncbi.nlm.nih.gov/pubmed/21436975
work_keys_str_mv AT valentinsheila safetyandefficacyofdoxycyclineinthetreatmentofrosacea
AT moralesadisbeth safetyandefficacyofdoxycyclineinthetreatmentofrosacea
AT sanchezjorgel safetyandefficacyofdoxycyclineinthetreatmentofrosacea
AT riveraabimael safetyandefficacyofdoxycyclineinthetreatmentofrosacea